Skip to content

Towards a more custom tailored treatment of obesity: Subtyping the motivation to overeat

Towards a more custom tailored treatment of obesity: Subtyping the motivation to overeat - Analyses of eating behavior

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41567
Enrollment
400
Registered
2012-05-15
Start date
2012-10-31
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesitas obesity overweight

Interventions

None listed

Sponsors

Alan Turing Institute Almere
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subjects must be between 18 and 70 years of age 2. BMI

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Use of psychoactive medication (ATC groups N03 through N07), or medication with significant psychoactive side-effects, currently or during the past 3 months, including, but not restricted to antidepressants, psychostimulants and antipsychotics. 3. Use of medication with significant effects on body weight, currently or during the past 3 months, with the exception of drugs used for treatment of comorbidities of obesity (e.g. rosiglitazone). 4. Significant use of illicit psychoactive substances, currently or during the past 3 months as reported by the participant. 5. Abuse of or dependence on legal psychoactive substances (alcohol, nicotine, cannabis), currently or during the past 3 months.

Design outcomes

Primary

MeasureTime frame
The classification of the obese into three subtypes for their motivation to overeat, and the role of genetic and biochemical variations. We expect to identify: !) hedonic eaters, 2) Reward deficient eaters, 3) Stress-activated eaters. After initial data analysis using conventional statistics, antropometric, psychological, biochemical and genetic data will be entered in a unique heterogeneous multi-agent system, developed and available at ATIA, allowing the identification of unexpected nonlinear correlations between parameters, providing information on previously unknown interactions, which will provide further insight in the development of obesity in our study participants.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)